Gary Sender - Net Worth and Insider Trading

Gary Sender Net Worth

The estimated net worth of Gary Sender is at least $0 dollars as of 2024-09-20. Gary Sender is the CFO of Nabriva Therapeutics PLC and owns about 77 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Gary Sender is also the Director of Schrodinger Inc and owns about 0 shares of Schrodinger Inc (SDGR) stock worth over $0. Details can be seen in Gary Sender's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary Sender has not made any transactions after 2021-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gary Sender

To

Gary Sender Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gary Sender owns 5 companies in total, including iBio Inc (IBIO) , Nabriva Therapeutics PLC (NBRVF) , and Harmony Biosciences Holdings Inc (HRMY) among others .

Click here to see the complete history of Gary Sender’s form 4 insider trades.

Insider Ownership Summary of Gary Sender

Ticker Comapny Transaction Date Type of Owner
IBIO iBio Inc 2020-10-14 director
NBRVF Nabriva Therapeutics PLC 2019-08-21 Chief Financial Officer
HRMY Harmony Biosciences Holdings Inc 2020-08-18 director
LIMIT LIMIT 2021-03-08 director
LIMIT LIMIT 2015-11-16 EVP and CFO

Gary Sender Latest Holdings Summary

Gary Sender currently owns a total of 2 stocks. Among these stocks, Gary Sender owns 77 shares of Nabriva Therapeutics PLC (NBRVF) as of August 21, 2019, with a value of $0 and a weighting of 100%. Gary Sender also owns 0 shares of Schrodinger Inc (SDGR) as of March 8, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Gary Sender

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBRVF Nabriva Therapeutics PLC 2019-08-21 77 0.00 0
SDGR Schrodinger Inc 2021-03-08 0 20.82 0

Holding Weightings of Gary Sender


Gary Sender Form 4 Trading Tracker

According to the SEC Form 4 filings, Gary Sender has made a total of 0 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years. The most-recent trade in Nabriva Therapeutics PLC is the sale of 14 shares on August 21, 2019, which brought Gary Sender around $7,051.

According to the SEC Form 4 filings, Gary Sender has made a total of 1 transactions in Schrodinger Inc (SDGR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Schrodinger Inc is the sale of 28,775 shares on March 8, 2021, which brought Gary Sender around $2 Million.

Insider Trading History of Gary Sender

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gary Sender Trading Performance

GuruFocus tracks the stock performance after each of Gary Sender's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary Sender is -35.42%. GuruFocus also compares Gary Sender's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary Sender within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gary Sender's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gary Sender

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -21.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -22.88 LIMIT LIMIT LIMIT LIMIT LIMIT

Gary Sender Ownership Network

Ownership Network List of Gary Sender

No Data

Ownership Network Relation of Gary Sender

Insider Network Chart

Gary Sender Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Gary Sender is the director of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Gary Sender made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 84,655 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,233 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,233 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iBio Inc Insider Transactions

No Available Data

Gary Sender Mailing Address

Above is the net worth, insider trading, and ownership report for Gary Sender. You might contact Gary Sender via mailing address: C/o Synergy Pharmaceuticals Inc., 420 Lexington Ave, New York Ny 10020.

Discussions on Gary Sender

No discussions yet.